Works matching IS 00071048 AND DT 2015 AND VI 170 AND IP 1

Results: 20

Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 5, doi. 10.1111/bjh.13363

By:

Key, Nigel S.;
Connes, Philippe;
Derebail, Vimal K.

Publication type:

Article

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 40, doi. 10.1111/bjh.13380

By:

Österborg, Anders;
Wierda, William G.;
Mayer, Jiří;
Hess, Georg;
Hillmen, Peter;
Schetelig, Johannes;
Schuh, Anna;
Smolej, Lukáš;
Beck, Christian;
Dreyfus, Brigitte;
Hellman, Andrzej;
Kozlowski, Piotr;
Pfreundschuh, Michael;
Rizzi, Rita;
Spacek, Martin;
Phillips, Jennifer L.;
Gupta, Ira V.;
Williams, Vanessa;
Jewell, Roxanne C.;
Nebot, Noelia

Publication type:

Article

Acute myeloid leukaemia: challenges and real world data from India.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 110, doi. 10.1111/bjh.13406

By:

Philip, Chepsy;
George, Biju;
Ganapule, Abhijeet;
Korula, Anu;
Jain, Punit;
Alex, Ansu Abu;
Lakshmi, Kavitha M.;
Sitaram, Usha;
Abubacker, Fouzia N.;
Abraham, Aby;
Viswabandya, Auro;
Srivastava, Vivi M.;
Srivastava, Alok;
Balasubramanian, Poonkuzhali;
Mathews, Vikram

Publication type:

Article

Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 50, doi. 10.1111/bjh.13386

By:

Ganzel, Chezi;
Devlin, Sean;
Douer, Dan;
Rowe, Jacob M.;
Stein, Eytan M.;
Tallman, Martin S.

Publication type:

Article

c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 123, doi. 10.1111/bjh.13261

By:

Kumar, Riten;
Dawson, Jennifer E.;
Chan, Anthony K. C.;
Forman‐Kay, Julie D.;
Kahr, Walter H. A.;
Williams, Suzan

Publication type:

Article

Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 125, doi. 10.1111/bjh.13269

By:

Thompson, Philip A.;
Ferrajoli, Alessandra;
O'Brien, Susan;
Wierda, William G.;
Keating, Michael J.;
Burger, Jan A.

Publication type:

Article

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 96, doi. 10.1111/bjh.13400

By:

Bates, Susan E.;
Eisch, Robin;
Ling, Alexander;
Rosing, Douglas;
Turner, Maria;
Pittaluga, Stefania;
Prince, H. Miles;
Kirschbaum, Mark H.;
Allen, Steven L.;
Zain, Jasmine;
Geskin, Larisa J.;
Joske, David;
Popplewell, Leslie;
Cowen, Edward W.;
Jaffe, Elaine S.;
Nichols, Jean;
Kennedy, Sally;
Steinberg, Seth M.;
Liewehr, David J.;
Showe, Louise C.

Publication type:

Article

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 118, doi. 10.1111/bjh.13388

By:

Horton, Terzah M.;
Drachtman, Richard A.;
Chen, Lu;
Cole, Peter D.;
McCarten, Kathleen;
Voss, Stephan;
Guillerman, Robert P.;
Buxton, Allen;
Howard, Scott C.;
Hogan, Shirley M.;
Sheehan, Andrea M.;
López‐Terrada, Dolores;
Mrazek, Matthew D.;
Agrawal, Neeraj;
Wu, Meng‐Fen;
Liu, Hao;
De Alarcon, Pedro A.;
Trippet, Tanya M.;
Schwartz, Cindy L.

Publication type:

Article

Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 56, doi. 10.1111/bjh.13389

By:

Swinnen, Lode J.;
Li, Hailun;
Quon, Andrew;
Gascoyne, Randy;
Hong, Fangxin;
Ranheim, Erik A.;
Habermann, Thomas M.;
Kahl, Brad S.;
Horning, Sandra J.;
Advani, Ranjana H.

Publication type:

Article

Estimating tissue iron burden: current status and future prospects.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 15, doi. 10.1111/bjh.13374

By:

Wood, John C.

Publication type:

Article

Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 66, doi. 10.1111/bjh.13394

By:

Dytfeld, Dominik;
Rosebeck, Shaun;
Kandarpa, Malathi;
Mayampurath, Anoop;
Mellacheruvu, Dattatreya;
Alonge, Mattina M.;
Ngoka, Lambert;
Jasielec, Jagoda;
Richardson, Paul G.;
Volchenboum, Samuel;
Nesvizhskii, Alexey I.;
Sreekumar, Arun;
Jakubowiak, Andrzej J.

Publication type:

Article

Primary bilateral diffuse large B-cell lymphoma of the adrenals.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 3, doi. 10.1111/bjh.13466

By:

Martínez‐Esteve, Andrés;
García‐Gómez, Francisco J.;
Madrigal‐Toscano, María D.;
Borrego‐Dorado, Isabel

Publication type:

Article

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 85, doi. 10.1111/bjh.13399

By:

Nabhan, Chadi;
Byrtek, Michelle;
Rai, Ashish;
Dawson, Keith;
Zhou, Xiaolei;
Link, Brian K.;
Friedberg, Jonathan W.;
Zelenetz, Andrew D.;
Maurer, Matthew J.;
Cerhan, James R.;
Flowers, Christopher R.

Publication type:

Article

First reported duplication of the entire beta globin gene cluster causing an unusual sickle cell trait phenotype.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 128, doi. 10.1111/bjh.13274

By:

Shooter, Claire;
Senior McKenzie, Tania;
Oakley, Matthew;
Jacques, Tracey;
Clark, Barnaby;
Thein, Swee Lay

Publication type:

Article

Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 29, doi. 10.1111/bjh.13379

By:

Mead, Adam J.;
Milojkovic, Dragana;
Knapper, Steven;
Garg, Mamta;
Chacko, Joseph;
Farquharson, Mira;
Yin, John;
Ali, Sahra;
Clark, Richard E.;
Andrews, Chris;
Dawson, Meryem Ktiouet;
Harrison, Claire

Publication type:

Article

Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 131, doi. 10.1111/bjh.13275

By:

Furtado, Michelle;
Wang, Michael L.;
Munneke, Brian;
McGreivy, Jesse;
Beaupre, Darrin M.;
Rule, Simon

Publication type:

Article

An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38low blasts.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 80, doi. 10.1111/bjh.13398

By:

Khan, Naeem;
Freeman, Sylvie D.;
Virgo, Paul;
Couzens, Steve;
Richardson, Peter;
Thomas, Ian;
Grech, Angela;
Vyas, Paresh;
Grimwade, David;
Russell, Nigel H.;
Burnett, Alan K.;
Hills, Robert K.

Publication type:

Article

Aleukaemic leukaemia cutis.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 4, doi. 10.1111/bjh.13468

By:

Mangla, Ankit;
Mushtaq, Muhammad U.;
Catchatourian, Rosalind

Publication type:

Article

Real world data on acute myeloid leukaemia therapy from the developing world - an eye-opener.

Published in:

2015

By:

Hokland, Peter;
Cotter, Finbarr

Publication type:

Editorial

The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 134, doi. 10.1111/bjh.13278

By:

Cao, Yang;
Yang, Guang;
Hunter, Zachary R.;
Liu, Xia;
Xu, Lian;
Chen, Jie;
Tsakmaklis, Nickolas;
Hatjiharissi, Evdoxia;
Kanan, Sandra;
Davids, Matthew S.;
Castillo, Jorge J.;
Treon, Steven P.

Publication type:

Article

Works matching IS 00071048 AND DT 2015 AND VI 170 AND IP 1

Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.

Acute myeloid leukaemia: challenges and real world data from India.

Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy.

c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency.

Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).

Estimating tissue iron burden: current status and future prospects.

Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens.

Primary bilateral diffuse large B-cell lymphoma of the adrenals.

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.

First reported duplication of the entire beta globin gene cluster causing an unusual sickle cell trait phenotype.

Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial.

Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.

An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34<sup>+</sup> CD38<sup>low</sup> blasts.

Aleukaemic leukaemia cutis.

Real world data on acute myeloid leukaemia therapy from the developing world - an eye-opener.

The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4<sup> Wild-type</sup> and CXCR4 <sup> WHIM</sup> mutated Waldenstrom macroglobulinaemia cells.